• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期帕金森病的严重夜间异动症:临床描述、与血浆左旋多巴的关系及治疗

Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.

作者信息

Zimmerman T R, Sage J I, Lang A E, Mark M H

机构信息

Department of Neurology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick 08903.

出版信息

Mov Disord. 1994 Mar;9(2):173-7. doi: 10.1002/mds.870090208.

DOI:10.1002/mds.870090208
PMID:8196678
Abstract

We report four patients with Parkinson's disease who had an unusual pattern of severe chorea and dystonia in the evenings only. The temporal pattern of abnormal movements and simultaneous monitoring of plasma levodopa and clinical state were consistent with dyskinesias associated with subtherapeutic (low dopa dyskinesias) rather than peak concentrations of levodopa (high dopa dyskinesias). In two patients, addition of a direct-acting dopamine receptor agonist was helpful in ameliorating this complication of antiparkinson therapy.

摘要

我们报告了4例帕金森病患者,他们仅在傍晚出现一种不寻常的严重舞蹈症和肌张力障碍模式。异常运动的时间模式以及血浆左旋多巴和临床状态的同步监测结果与低于治疗剂量相关的异动症(低剂量多巴异动症)而非左旋多巴峰值浓度相关的异动症(高剂量多巴异动症)相符。在2例患者中,加用一种直接作用的多巴胺受体激动剂有助于改善抗帕金森治疗的这一并发症。

相似文献

1
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.晚期帕金森病的严重夜间异动症:临床描述、与血浆左旋多巴的关系及治疗
Mov Disord. 1994 Mar;9(2):173-7. doi: 10.1002/mds.870090208.
2
High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.高剂量培高利特单一疗法治疗严重左旋多巴诱发的运动障碍。
Mov Disord. 1996 May;11(3):327-9. doi: 10.1002/mds.870110319.
3
[Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease].[缓释左旋多巴/苄丝肼治疗帕金森病剂末运动不能的疗效]
Nervenarzt. 1995 Dec;66(12):933-41.
4
Square-wave action dystonia in Parkinson's disease.帕金森病中的方波动作性肌张力障碍
Mov Disord. 1998 Mar;13(2):354-6. doi: 10.1002/mds.870130228.
5
Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio).帕金森病中与运动波动和异动症相关的因素:新型美左旋多巴加卡比多巴制剂(Sirio)的潜在作用
Clin Neuropharmacol. 2010 Jul;33(4):198-203. doi: 10.1097/WNF.0b013e3181de8924.
6
Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.盐酸多奈哌齐与左旋多巴/卡比多巴联合用于帕金森病患者:多次口服给药后药代动力学变化及安全性评估
Br J Clin Pharmacol. 2004 Nov;58 Suppl 1(Suppl 1):41-9. doi: 10.1111/j.1365-2125.2004.01799.x.
7
Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa.左旋多巴/卡比多巴液剂和片剂的血浆左旋多巴及运动反应波动情况
Mov Disord. 1994 Jul;9(4):463-5. doi: 10.1002/mds.870090416.
8
Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.左旋多巴+卡比多巴+恩他卡朋。恩他卡朋:再审视:新制剂。帕金森病:疗效一般。
Prescrire Int. 2005 Apr;14(76):51-4.
9
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.帕金森病中左旋多巴诱发的异动症:现象学与病理生理学
Mov Disord. 1994 Jan;9(1):2-12. doi: 10.1002/mds.870090103.
10
New concepts in the treatment of Parkinson's disease.帕金森病治疗的新概念。
Am Fam Physician. 1990 Feb;41(2):574-84.

引用本文的文献

1
Too little or too much nocturnal movements in Parkinson's disease: A practical guide to managing the unseen.帕金森病夜间活动过少或过多:管理隐匿问题的实用指南
Clin Park Relat Disord. 2024 May 25;10:100258. doi: 10.1016/j.prdoa.2024.100258. eCollection 2024.
2
A video-atlas of levodopa-induced dyskinesia in Parkinson's disease: terminology matters.帕金森病左旋多巴诱导性异动症的视频图谱:术语很重要。
Neurol Sci. 2024 Apr;45(4):1389-1397. doi: 10.1007/s10072-023-07209-6. Epub 2023 Nov 21.
3
Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys.
局部纹状体多巴胺可能会增强帕金森病猴的运动障碍。
Exp Neurol. 2006 Feb;197(2):363-72. doi: 10.1016/j.expneurol.2005.10.022. Epub 2005 Dec 9.
4
Drug-induced movement disorders.药物性运动障碍
Drug Saf. 1997 Mar;16(3):180-204. doi: 10.2165/00002018-199716030-00004.
5
Pharmacokinetic optimisation in the treatment of Parkinson's disease.帕金森病治疗中的药代动力学优化
Clin Pharmacokinet. 1996 Jun;30(6):463-81. doi: 10.2165/00003088-199630060-00004.